Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Herceptin was an example of a 'therapeutic antibody' and was the first of its type for cancer treatment. Antibodies are proteins in our immune system ...
The immune system learns to recognise that the protein comes from a virus or a ... It can be used to develop new immunotherapies against cancer, ...
Thus, pembrolizumab-mediated blocking of PD-1 allows the immune system to adequately fight cancer cells. A research team led by Joshua Bauml, ...
... the innate immune system. This finding is crucial for the creation of new drugs to target TLR9 as an immunotherapeutic approach against cancer, ...
We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an ...
Last month, VolitionRx announced a new set of data from a study into whether the NuQ® technology could pick up pancreatic cancer. The company ...
... seeking orphan drug status for Reolysin for high-grade gliomas (pediatric patients) in the U.S. and pancreatic cancer in the U.S. and the EU.
... linked to smoking were: mouth cancers, esophageal cancer, stomach cancer, colorectal cancer, liver cancer, pancreatic cancer, laryngeal cancer, ...
There has been increasing evidence that micro and messenger RNA derived from exosomes play important roles in pancreatic and other cancers.
The example the authors give of a rare but remarkable response to a kidney cancer drug in a patient with bladder cancer makes the point.
Participants developed a wide range of cancers, including skin, prostate, breast, lung and bladder cancer. “If you've had a stroke before, especially ...
Theralase Technologies (TSX: V.TLT, Stock Forum) hit another home run when the company announced today that research on its anti-cancer ...
Theralase's Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug -MarketWatch
... lung cancer, bladder cancer, kidney cancer, acute myeloid leukemia, diabetes, ischemic heart disease, other heart disease, stroke, atherosclerosis, ...
TAMPA — Pancreatic cancer affects approximately 46,000 people each year in the United States and ranks fourth among the leading causes of ...
Figures from the American Cancer Society show that only about 6 to 7 percent of those diagnosed with pancreatic cancer will live five years, he said ...
In commenting on the efficacy of such antibodies in the treatment of cancer, ... If a tumor is so aggressive (e.g. melanoma, pancreatic cancer, etc.) ...
Garrett said he's seen people experience a medical need for marijuana as a last resort, including his father-in-law, who dealt with pancreatic cancer.
Patients with pancreatic cancer, for which there are few personalised drugs licensed in Europe, made the least use of personalised medicines, with ...
The Role of Radiotherapy in Node-Positive Prostate Cancer
This article summarizes the existing literature on use of radiotherapy for node-positive prostate cancer, as well as the associated outcomes. Studies that examined the use of radiotherapy as definitive treatment and as adjuvant therapy after radical prostatectomy are reviewed separately.
This article summarizes the existing literature on use of radiotherapy for node-positive prostate cancer, as well as the associated outcomes. Studies that examined the use of radiotherapy as definitive treatment and as adjuvant therapy after radical prostatectomy are reviewed separately.
commentaries
Radiation Therapy for Node-Positive Prostate Cancer: It's Time for a Randomized Trial
We are in urgent need of a randomized trial comparing radiation plus ADT vs ADT alone for men with node-positive prostate cancer.
We are in urgent need of a randomized trial comparing radiation plus ADT vs ADT alone for men with node-positive prostate cancer.
Node-Positive Prostate Cancer: A Call for Level 1 Evidence
Despite the lack of level 1 evidence, retrospective studies support the need for appropriate local treatment, even in the context of node-positive disease.
Despite the lack of level 1 evidence, retrospective studies support the need for appropriate local treatment, even in the context of node-positive disease.
Science Daily Cancer News
Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.
Taking hormone replacement therapy (HRT) for menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence.
A study of stroke survivors showed that having a stroke was linked with an increased risk of having an underlying cancer. Stroke survivors who develop cancer have a three-times higher risk of dying compared to survivors who don't get cancer.
Surgeons rely on 200-year-old technology when removing cancer -- sight and touch -- to determine how much to remove and what to leave alone. Laser technology has the promise to help a surgeon better determine if an area is cancer or healthy tissue. Moreover, when combined with laser treatment for cancer, this work lays the groundwork for laser robotic treatment of cancer.
Tambahkan Komentar